Cerebrovascular risk factors and their time-dependent effects on stroke survival in the EMMA cohort study.
Journal
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas
ISSN: 1414-431X
Titre abrégé: Braz J Med Biol Res
Pays: Brazil
ID NLM: 8112917
Informations de publication
Date de publication:
2023
2023
Historique:
received:
09
06
2023
accepted:
09
08
2023
medline:
2
11
2023
pubmed:
4
10
2023
entrez:
4
10
2023
Statut:
epublish
Résumé
To investigate the time-dependent effects of traditional risk factors on functional disability in all-cause mortality post-stroke, we evaluated data from a long-term stroke cohort. Baseline cerebrovascular risk factors (CVRF) and functionality at 1 and 6 months were evaluated in survivors from a prospective stroke cohort using the modified Rankin scale (m-RS), which classifies participants as improvement of disability, unchanged disability (at least moderate), and worsening disability. Cox regression models considering baseline risk factors, medication use, and functionality 6 months after stroke were fitted to identify their time-dependent effects up to 12 years of follow-up. Adjusted hazard ratios (HR) with 95% confidence intervals (CI) are presented. Among 632 survivors (median age 68, 54% male, 71% first-ever episode), age and functional disability (unchanged and worsening) 6 months after ischemic stroke had time-dependent effects on all-cause mortality risk up to 12 years of follow-up. The most impacting risk factors were unchanged (at least moderate) (HR, 2.99; 95%CI: 1.98-4.52) and worsening disability (HR, 2.85; 95%CI: 1.26-6.44), particularly in the first two years after a stroke event (Time 1: ≥6 mo to <2.5 y). Worsening disability also impacted mortality in the period from ≥2.5 to <7.5 years (Time 2) of follow-up (HR, 2.43 (95%CI: 1.03-5.73). Other baseline factors had a fixed high-risk effect on mortality during follow-up. Post-stroke and continuous medication use had a fixed protective effect on mortality. Functional disability was the main contributor with differential risks of mortality up to 12 years of follow-up.
Identifiants
pubmed: 37792780
pii: S0100-879X2023000100668
doi: 10.1590/1414-431X2023e12895
pmc: PMC10515500
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e12895Références
BMC Med Res Methodol. 2010 Mar 16;10:20
pubmed: 20233435
Am J Epidemiol. 2008 Feb 15;167(4):492-9
pubmed: 18056625
J Stroke Cerebrovasc Dis. 2016 Mar;25(3):618-25
pubmed: 26725125
J Neurosci Nurs. 2022 Apr 1;54(2):80-85
pubmed: 35175989
Stroke. 1989 Jun;20(6):828
pubmed: 2728057
Lancet Neurol. 2007 May;6(5):387-8; author reply 388-9
pubmed: 17434087
Kidney Int. 2008 Oct;74(8):994-7
pubmed: 18633346
Cad Saude Publica. 2012 Aug;28(8):1581-90
pubmed: 22892977
BMC Neurol. 2013 May 24;13:51
pubmed: 23706067
Stroke. 2019 Dec;50(12):3385-3392
pubmed: 31699020
Arch Phys Med Rehabil. 2017 Apr;98(4):722-729
pubmed: 27744024
Lancet Neurol. 2019 May;18(5):439-458
pubmed: 30871944
PLoS One. 2014 Feb 04;9(2):e87884
pubmed: 24504327
Int J Stroke. 2022 Jan;17(1):48-58
pubmed: 33527882
Clin Neuropharmacol. 2011 Nov-Dec;34(6):234-40
pubmed: 21996648
Stroke. 2012 Mar;43(3):851-3
pubmed: 22135076
Ann Med. 2019 Feb;51(1):68-77
pubmed: 30592437
BMJ. 2010 Mar 12;340:b5087
pubmed: 20228141
Eur J Neurol. 2020 Mar;27(3):579-585
pubmed: 31721389
Int J Stroke. 2010 Aug;5(4):284-9
pubmed: 20636711
Cerebrovasc Dis. 2017;44(3-4):232-239
pubmed: 28848194